Vaccination Protects Spring Breakers From Dengue

Dengue virus is a severe ongoing concern for many areas of Central and South America, Mexico, and the Caribbean.

If you plan to visit any high-risk areas during Spring Break 2024, don't let dengue fever ruin your trip.

The high-risk destination list includes Argentina, Brazil, Colombia, Costa Rica, French Guiana, Guadeloupe, Guatemala, Haiti, Jamaica, Martinique, Mexico (Cancun), Nicaragua, Panama, Paraguay, Peru, Saint Barthelemy, Saint Martin, Turks and Caicos Islands.

The U.S. Centers for Disease Control and Prevention (CDC) confirmed on February 28, 2024, travelers should protect themselves by taking precautions against mosquito bites. Take the necessary measures to safeguard yourself and enjoy a worry-free trip.

However, be aware the disease can take up to two weeks to develop, and the illness generally lasts less than a week.

Additionally, the CDC says don't disrupt your vacation with this vaccine-preventable illness.

As of March 12, 2024, various government agencies have approved dengue vaccines, and several vaccine candidates are conducting late-stage studies.

In the U.S., Dengvaxia® is approved by the U.S. FDA. On June 30, 2023, the FDA issued a Supplemental Approval letter.

Other countries offer QDENGA®, a WHO-recommended dengue vaccine.